Abstract
Complicated Grief (CG) is a loss-specific affective disorder that has been shown to respond to psychotherapy. The evidence for pharmacological treatment of this disorder is more limited, but given the time-intensive nature and limited availability of evidence-based therapy in the community, medications remain an important adjunctive intervention deserving of further study. In addition, the death of a loved one may precipitate or exacerbate one of several psychiatric conditions, including acute stress disorder, posttraumatic stress disorder, and major depressive disorder. This chapter reviews the clinical and neurobiological rationale for a pharmacologic approach to treating CG, and the evidence base for antidepressant agents and other medications in the treatment of this condition. Pharmacological treatments of other loss-related conditions will also be briefly reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
APA. Diagnostic and statistical manual of mental disorders DSM5. 5th ed. Washington DC: American Psychiatric Publishing; 2013.
Shear K, Frank E, Houck PR, Reynolds CF 3rd. Treatment of complicated grief: a randomized controlled trial. JAMA. 2005;293(21):2601–8.
Shear MK, Frank E, Foa E, Cherry C, Reynolds CF III, Vander Bilt J, et al. Traumatic grief treatment: a pilot study. Am J Psychiatry. 2001;158(9):1506–8.
Shear MK, Reynolds CF 3rd, Simon NM, Zisook S, Wang Y, Mauro C, et al. Optimizing treatment of complicated grief: a randomized clinical trial. JAMA Psychiatry. 2016;73(7):685–94.
Fontenot MB, Kaplan JR, Manuck SB, Arango V, Mann JJ. Long-term effects of chronic social stress on serotonergic indices in the prefrontal cortex of adult male cynomolgus macaques. Brain Res. 1995;705(1–2):105–8.
Prigerson HG, Shear MK, Jacobs SC, Reynolds CF 3rd, Maciejewski PK, Davidson JR, et al. Consensus criteria for traumatic grief. A preliminary empirical test. Br J Psychiatry. 1999;174:67–73.
Shear MK, Simon N, Wall M, Zisook S, Neimeyer R, Duan N, et al. Complicated grief and related bereavement issues for DSM-5. Depress Anxiety. 2011;28(2):103–17.
Jacobs SC, Nelson JC, Zisook S. Treating depressions of bereavement with antidepressants. A pilot study. Psychiatr Clin North Am. 1987;10(3):501–10.
Pasternak RE, Reynolds CF 3rd, Schlernitzauer M, Hoch CC, Buysse DJ, Houck PR, et al. Acute open-trial nortriptyline therapy of bereavement-related depression in late life. J Clin Psychiatry. 1991;52(7):307–10.
Zisook S, Shuchter SR, Pedrelli P, Sable J, Deaciuc SC. Bupropion sustained release for bereavement: results of an open trial. J Clin Psychiatry. 2001;62(4):227–30.
Reynolds CF 3rd, Miller MD, Pasternak RE, Frank E, Perel JM, Cornes C, et al. Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry. 1999;156(2):202–8.
Zygmont M, Prigerson HG, Houck PR, Miller MD, Shear MK, Jacobs S, et al. A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief. J Clin Psychiatry. 1998;59(5):241–5.
Shear MK, Fagiolini A, Houck P, Simon N, Frank E, Reynolds C, et al. Escitalopram for complicated grief: a pilot study. In: NCDEU 46th annual meeting abstracts. Boca Raton, FL: National Institute of Mental Health; 2006.
Simon NM, Thompson EH, Pollack MH, Shear MK. Complicated grief: a case series using escitalopram. Am J Psychiatry. 2007;164(11):1760–1.
Hensley PL, Slonimski CK, Uhlenhuth EH, Clayton PJ. Escitalopram: an open-label study of bereavement-related depression and grief. J Affect Disord. 2009;113(1–2):142–9.
Warner J, Metcalfe C, King M. Evaluating the use of benzodiazepines following recent bereavement. Br J Psychiatry. 2001;178(1):36–41.
Davydow DS, Gifford JM, Desai SV, Needham DM, Bienvenu OJ. Posttraumatic stress disorder in general intensive care unit survivors: a systematic review. Gen Hosp Psychiatry. 2008;30(5):421–34.
Gelpin E, Bonne O, Peri T, Brandes D, Shalev AY. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry. 1996;57(9):390–4.
Mellman TA, Bustamante V, David D, Fins AI. Hypnotic medication in the aftermath of trauma. J Clin Psychiatry. 2002;63(12):1183–4.
Cook JM, Biyanova T, Marshall R. Medicating grief with benzodiazepines: physician and patient perspectives. Arch Intern Med. 2007;167(18):2006–7.
Simon NM, Shear MK, Fagiolini A, Frank E, Zalta A, Thompson EH, et al. Impact of concurrent naturalistic pharmacotherapy on psychotherapy of complicated grief. Psychiatry Res. 2008;159(1–2):31–6.
Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW. Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: systemic review and meta-analyses to determine first-line treatments. Depress Anxiety. 2016;33(9):792–806.
O'Connor MF, Wellisch DK, Stanton AL, Eisenberger NI, Irwin MR, Lieberman MD. Craving love? Enduring grief activates brain’s reward center. Neuroimage. 2008;42(2):969–72.
Insel TR. Is social attachment an addictive disorder? Physiol Behav. 2003;79(3):351–7.
Hendershot CS, Wardell JD, Samokhvalov AV, Rehm J. Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies. Addict Biol. 2016. https://doi.org/10.1111/adb.12425.
Hamilton JD, Nguyen QX, Gerber RM, Rubio NB. Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial. Am J Addict. 2009;18(1):48–52.
Kampman KM, Pettinati HM, Lynch KG, Whittingham T, Macfadden W, Dackis C, et al. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol. 2007;27(4):344–51.
O'Connor MF. Immunological and neuroimaging biomarkers of complicated grief. Dialogues Clin Neurosci. 2012;14(2):141–8.
O'Connor MF, Shear MK, Fox R, Skritskaya N, Campbell B, Ghesquiere A, et al. Catecholamine predictors of complicated grief treatment outcomes. Int J Psychophysiol. 2013;88(3):349–52.
Eisenberger NI. The neural basis of social pain: findings and implications. In: MacDonald G, Jensen-Campbell LA, editors. Social pain: neuropsychological and health implications of loss and exclusion. Washington, DC: American Psychological Association; 2010. p. 53–78.
Parkes C. Bereavement: studies of grief in later life. London: Tavistock; 1972.
Robinaugh DJ, LeBlanc NJ, Vuletich HA, McNally RJ. Network analysis of persistent complex bereavement disorder in conjugally bereaved adults. J Abnorm Psychol. 2014;123(3):510–22.
Dewall CN, Macdonald G, Webster GD, Masten CL, Baumeister RF, Powell C, et al. Acetaminophen reduces social pain: behavioral and neural evidence. Psychol Sci. 2010;21(7):931–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Vance, M.C., Bui, E. (2018). Pharmacotherapy of Pathological Grief Responses. In: Bui, E. (eds) Clinical Handbook of Bereavement and Grief Reactions . Current Clinical Psychiatry. Humana Press, Cham. https://doi.org/10.1007/978-3-319-65241-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-65241-2_13
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-65240-5
Online ISBN: 978-3-319-65241-2
eBook Packages: MedicineMedicine (R0)